Kelly L Hartel, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 W. Liberty, Parkland Health Center, Farmington, MO 63640 Phone: 573-760-8475 Fax: 573-760-8484 |
Dr. Dana R Day, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1010 W Columbia St, Farmington, MO 63640 Phone: 573-218-6792 |
Dr. Victor Beau Bailey, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1212 Weber Rd, Farmington, MO 63640 Phone: 573-756-4581 |
Dr. John Stephen Hunt, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1101 E. Liberty St., Farmington, MO 63640 Phone: 573-760-8475 Fax: 573-760-8475 |
Dr. Bruce E Harrison, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 204 Green Trail Dr, Farmington, MO 63640 Phone: 573-883-7786 |
Mark A Hassen, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1212 Weber Rd, Farmington, MO 63640 Phone: 573-701-7215 Fax: 573-701-7117 |
News Archive
John DeLuca, PhD, a clinical neuropsychologist and Senior Vice President of Research and Training at Kessler Foundation, is the co-chief editor of the new 2nd edition "Encyclopedia of Clinical Neuropsychology". Published by Springer, it is the first major encyclopedia of adult and pediatric neuropsychological disorders.
The trailblazing company whose Smart for Life weight management products featuring the cookie diet component has recently improved its Chocolate Chip Cookie to include the most protein offered in a meal replacement cookie on the market at a whopping 6 grams per serving. The amount of protein found in meal replacements is instrumental in curbing hunger, maintaining muscle mass, and providing energy, not to mention contributing to weight loss.
The University of Louisville Department of Pediatrics has been selected to receive the university's 2013 Paul Weber Award for Departmental Excellence in Teaching.
Researchers at the Stanford University School of Medicine have identified mutations in several new genes that might be associated with the development of spontaneously occurring cases of the neurodegenerative disease known as amyotrophic lateral sclerosis, or ALS.
Shire plc today announced it has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration for its investigational candidate, lifitegrast, for the treatment of signs and symptoms of dry eye disease in adults. Shire resubmitted the NDA in response to the complete response letter (CRL) the company received from the FDA on October 16, 2015.
› Verified 3 days ago